Up to 50% of patients treated with radical surgery for localized prostate cancer may
experience biochemical recurrence that requires appropriate management. Definitions of …

Background and purpose We examined the interfractional variations of clinical target
volumes (CTVs), planning target volumes (PTVs), and organs-at-risk (OARs) in patients …

At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically
localized form of the disease, with most of them presenting with low-or intermediate-risk …

Background Management of local recurrence of prostate cancer (PCa) in the prostatic bed
after radical prostatectomy (RP) and radiotherapy remains challenging. Objective To assess …

Background: The aim of this study was to investigate the feasibility of ultrahypofractionated
radiotherapy to the prostate bed in patients with biochemical and/or clinical relapse …

Purpose There are limited data regarding using stereotactic body radiation therapy (SBRT)
in the postprostatectomy setting. Here, we present a preliminary analysis of a prospective …

Introduction Prostate-specific membrane antigen (PSMA) is a transmembrane protein that
may be expressed on the surface of prostate cancer (PC) cells. It enables a more sensitive …

Simple Summary This article is a report about early toxicity and biochemical outcomes after
stereotactic salvage radiotherapy for macroscopic recurrence within prostate bed after …

Background While SBRT to the prostate has become a valuable option as a radical
treatment, limited data support its use in the postoperative setting. Here, we report the …

Purpose: To report the use of high-dose-rate (HDR) interventional radiotherapy
(brachytherapy, IRT) as a salvage treatment for macroscopic histologically confirmed local …